Non-invasive Monitoring of Cerebral Self-regulation in Perioperative Neonatal Cardiac Surgery (NEMOCARD)

March 11, 2022 updated by: Nantes University Hospital
Cardiac surgery under extracorporeal circulation (ECC) in newborns with congenital heart disease causes significant morbidity and mortality. The perioperative period is a period of major vulnerability implicated in the appearance of these sequelae, and it is therefore essential to monitor brain function during ECC. The quality of cerebral oxygenation in the perioperative period is routinely monitored non-invasively by infra-red spectroscopy, which makes it possible to estimate cerebral tissue oximetry from a surface electrode (NIRS). The association between time spent outside the limits of cerebral self-regulation and the occurrence of perioperative encephalopathy is not known. The purpose of this study is to determine whether disturbances in brain self-regulation during the operative period are associated with the occurrence of postoperative encephalopathy in children operated on for congenital heart disease in the neonatal period. The main objective of the research is to determine the association between time spent outside individually determined cerebral self-regulation limits and the appearance of brain lesions suggestive of low brain output. Secondary objectives will investigate the association between time spent outside self-regulatory limits and the occurrence of postoperative encephalopathy defined by clinical and encephalographic criteria and will study factors predictive of the development of postoperative encephalopathy.

Study Overview

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nantes, France
        • CHU de Nantes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 second to 4 weeks (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Any newborn (0-28 days) with congenital heart disease, hospitalized in the preoperative period at the Nantes University Hospital, for whom a decision is made to perform an operation under extracorporeal circulation, suitable to be transported for an MRI without risk, advice taken from the treating team.

Exclusion Criteria:

  • emergency cardiac surgery
  • Preoperative extracorporeal assistance
  • Preoperative intubation
  • Preoperative administration of inotropes
  • Pre-operative instability contra-indicating pre-operative MRI
  • Dependence on a pace maker contra-indicating MRI Imaging.
  • Parental consent refusal
  • Non-affiliation to a health security insurance

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: MRI
Pre-operative AND post-operative MRI
Pre and Post operative MRI

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
determine the association between time spent outside individually determined cerebral self-regulatory limits and the development of brain lesions suggestive of low brain output.
Time Frame: 6 weeks after cardiac surgery

duration of period outside cerebral self-regulatory limits, Number, size and extent of new lesions on post-operative MRI.

Patients will be classified into 2 categories according to whether or not there are new lesions on MRI.

The lesions retained will be infarcts, white matter lesions and intraparenchymal hemorrhages, classified according to the Magnetic Resonance Imaging Abnormality Scoring System.

6 weeks after cardiac surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
describe association between time spent outside self-regulatory limits and the occurrence of postoperative encephalopathy defined by clinical and encephalographic criteria.
Time Frame: 6 weeks after cardiac surgery
duration of period outside cerebral self-regulatory limits, Standardized clinical examination according to Amiel Tison at hospital discharge.
6 weeks after cardiac surgery
describe predictive factors of postoperative encephalopathy
Time Frame: day 1 (cardiac surgery)
duration of extra-corporal circulation,
day 1 (cardiac surgery)
describe predictive factors of postoperative encephalopathy
Time Frame: day 1 (cardiac surgery)
duration of aortic clamp
day 1 (cardiac surgery)
describe predictive factors of postoperative encephalopathy
Time Frame: day 1 (cardiac surgery)
duration of selective cerebral perfusion,
day 1 (cardiac surgery)
describe predictive factors of postoperative encephalopathy
Time Frame: day 1 (cardiac surgery)
duration of hypothermia deepness
day 1 (cardiac surgery)
describe predictive factors of postoperative encephalopathy
Time Frame: day 1 (cardiac surgery)
duration of critical NIRS
day 1 (cardiac surgery)
describe predictive factors of postoperative encephalopathy
Time Frame: day 1 (cardiac surgery)
duration of critical median arterial pression (PAM)
day 1 (cardiac surgery)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 10, 2020

Primary Completion (Actual)

February 19, 2022

Study Completion (Actual)

February 19, 2022

Study Registration Dates

First Submitted

February 27, 2020

First Submitted That Met QC Criteria

March 2, 2020

First Posted (Actual)

March 4, 2020

Study Record Updates

Last Update Posted (Actual)

March 28, 2022

Last Update Submitted That Met QC Criteria

March 11, 2022

Last Verified

March 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Congenital Heart Disease in Children

Clinical Trials on MRI

3
Subscribe